Access to pediatric rheumatology care -- a major challenge to improving outcome in juvenile idiopathic arthritis.

摘要

Juvenile idiopathic arthritis (JIA) is a heterogeneous group of diseases and is one of the most common chronic rheumatic diseases in children. Improving the outcome for children with JIA remains an important goal, with current management of severe JIA involving increasingly aggressive immunosuppressive agents.